Under construction – not a live service
Sign in
Not yet taking people in ItalyNo phase

Robotic and virtual reality rehabilitation for arm weakness and neglect after stroke

Tests a virtual reality arm rehabilitation program in adults with stroke and left-sided neglect.

Plain-language title generated from the registry record
Registry title: Robotic rEhabilitation sCenario fOr patieNts With NeglECT

Key facts

Where
Florence, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 80 years old?

Source: NCT06890481, who can take part

Where in Italy

  • IRCCS Fondazione Don Carlo Gnocchi onlusFlorence, ItalyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione Don Carlo Gnocchi ETS
Trial code
NCT06890481
Record updated
3 April 2025
Original description
The goal of this pilot clinical trial is to develop an integrated motor and cognitive rehabilitation program and evaluate the usability and acceptability of a new virtual reality scenario designed for the MOTORE device. This study will focus on the rehabilitation of the upper limbs in post-stroke patients with plegia and left-sided hemi-inattention. The main questions it aims to answer are:Read full original descriptionShow less

Collaborative Development of a Virtual Reality Scenario, Integrated Into a Robotic Upper Limb Rehabilitation Device, for the Treatment of Unilateral Spatial Negligence (NSU) Through Mutisensory Stimulation: Feasibility and Usability Pilot Study

The goal of this pilot clinical trial is to develop an integrated motor and cognitive rehabilitation program and evaluate the usability and acceptability of a new virtual reality scenario designed for the MOTORE device. This study will focus on the rehabilitation of the upper limbs in post-stroke patients with plegia and left-sided hemi-inattention. The main questions it aims to answer are:

* The evaluation of the usability and acceptability of the newly developed scenario * The evaluation of the effects of the new scenario on patients' hemi-inattention * The evaluation of changes in upper limb functional parameters

Participants will undergo a total of 13 rehabilitation sessions, each lasting 45 minutes, using the new scenario, including an initial and final assessment.

Inclusion: Presence of a diagnosis of right hemispheric stroke; Presence of a diagnosis of hemi-inattention (Apple test); Presence of left hemiplegia (Fugl-Meyer Assessment Upper Limb ≤58); Adjusted Montreal Cognitive Assessment <20; Written informed consent.

Exclusion: Presence of cognitive decline prior to the event; Presence of previous stroke events; Orthopaedic, neurological, or psychiatric disorders that could interfere with the study procedures and motor or cognitive assessments; Presence of osteoarticular rigidity (e.g., ankylosis, functional limitations with traumatic or degenerative origin) or spasticity in the affected upper limb (Modified Ashworth Scale ≥3 on shoulder, elbow, or wrist); Inability to maintain a sitting position; Presence of severe visual disabilities; Recent injection of botulinum toxin in the upper limb or planned injection of botulinum toxin during the study period; Unstable fractures of the upper limb; Severe osteoporosis; Skin lesions on the upper limb.

ClinicalTrials.gov NCT06890481